Nikulski Financial’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,730
Closed -$252K 134
2023
Q2
$252K Sell
1,730
-300
-15% -$40.8K 0.1% 112
2023
Q1
$262K Hold
2,030
0.12% 113
2022
Q4
$259K Sell
2,030
-100
-5% -$11.6K 0.12% 107
2022
Q3
$223K Hold
2,130
0.12% 114
2022
Q2
$224K Hold
2,130
0.11% 117
2022
Q1
$272K Sell
2,130
-569
-21% -$68.6K 0.12% 109
2021
Q4
$333K Sell
2,699
-309
-10% -$40.4K 0.14% 101
2021
Q3
$427K Sell
3,008
-51
-2% -$7.5K 0.2% 88
2021
Q2
$474K Sell
3,059
-201
-6% -$32.6K 0.22% 87
2021
Q1
$507K Sell
3,260
-309
-9% -$47.9K 0.26% 76
2020
Q4
$534K Sell
3,569
-206
-5% -$29.1K 0.29% 69
2020
Q3
$499K Hold
3,775
0.32% 65
2020
Q2
$437K Hold
3,775
0.31% 65
2020
Q1
$370K Buy
+3,775
New +$495K 0.32% 63

Other funds holding ZBH

Nikulski Financial's ZBH Position: Q3 2023 in Review

Nikulski Financial sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 1,730 shares — an estimated $252K sold.

Nikulski Financial first reported a position in ZBH in Q1 2020 and held it in 14 quarters. The position peaked at $534K in Q4 2020. 1,017 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

  • Nikulski Financial reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
  • Nikulski Financial sold 1,730 Zimmer Biomet shares in Q3 2023, an estimated $252K.
  • Nikulski Financial first reported a position in Zimmer Biomet in Q1 2020 and held it in 14 quarters.
  • Nikulski Financial's Zimmer Biomet position peaked at $534K in Q4 2020.
  • 1,017 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Nikulski Financial's 13F filing for Q3 2023, filed 17 Oct 2023.